×
MOTS-C 10mg Research Peptide NAD+ 500mg Research Compound
First Order Offer
RMJS 1,000+ researchers subscribed

Get 10% Off
Your First Order

Purity-verified research compounds with third-party COAs. Fast shipping from Colorado.

Order before 12 PM MST — ships same day
99%+ Purity Secure Checkout COA Verified
No thanks, I'll pay full price No spam. Unsubscribe anytime. For research use only.

You're In!

Check your email for your exclusive 10% discount code.

Shop Now
🚚 FREE SHIPPING on all orders over $150✦⏱ Order before 12 PM MT — ships the same day✦🧪 99%+ purity — third-party COA with every batch✦💳 Pay by Card, Venmo, Zelle, ACH or Cash App✦🎁 FREE bacteriostatic water with every order✦📱 Customer care — Text us: (720) 285-5706✦🌐 Shipped from Denver, Colorado✦🚚 FREE SHIPPING on all orders over $150✦⏱ Order before 12 PM MT — ships the same day✦🧪 99%+ purity — third-party COA with every batch✦💳 Pay by Card, Venmo, Zelle, ACH or Cash App✦🎁 FREE bacteriostatic water with every order✦📱 Customer care — Text us: (720) 285-5706✦🌐 Shipped from Denver, Colorado✦🚚 FREE SHIPPING on all orders over $150✦⏱ Order before 12 PM MT — ships the same day✦🧪 99%+ purity — third-party COA with every batch✦💳 Pay by Card, Venmo, Zelle, ACH or Cash App✦🎁 FREE bacteriostatic water with every order✦📱 Customer care — Text us: (720) 285-5706✦🌐 Shipped from Denver, Colorado✦🚚 FREE SHIPPING on all orders over $150✦⏱ Order before 12 PM MT — ships the same day✦🧪 99%+ purity — third-party COA with every batch✦💳 Pay by Card, Venmo, Zelle, ACH or Cash App✦🎁 FREE bacteriostatic water with every order✦📱 Customer care — Text us: (720) 285-5706✦🌐 Shipped from Denver, Colorado✦
Free VectorFam Slider Case with 10 or more research vials — automatically added at checkout.
Shop Now

Author: Vector Team

Research blog

SS-31 (Elamipretide): The FDA-Approved Mitochondrial Peptide Redefining 2026 Research

By Vector Amino Labs Research Team The landscape of mitochondrial research shifted dramatically in late 2025 when the FDA approved elamipretide (formerly known in research circles as SS-31) for the treatment of Barth syndrome. This milestone marked the first time a mitochondria-targeted peptide received FDA approval, validating decades of research into cardiolipin-binding therapies. The Mechanism […]

Vector Team

By Vector Team

Read More